A complete application in a minute
Tailored resume and cover letter, ready to send.
GlaxoSmithKline plc in London is seeking a senior pharmacovigilance leader to oversee safety evaluation and risk management for HIV assets in clinical development. You will interpret data, identify safety signals, and deliver evidence-based recommendations to support benefit-risk decisions.
The role requires GMC registration, postgraduate training, and extensive experience in pharmacovigilance, with matrix leadership across global teams.
Provides medical and scientific leadership in the safety evaluation and risk management of GSK's HIV assets in clinical development. Responsible for the interpretation of safety data, identification and escalation of safety signals, and delivery of clear, evidence-based recommendations to support benefit-risk decisions. This role contributes to global governance and plays a critical part in protecting patient safety and shaping the safety profile of innovative oncology medicines.
This is an opportunity to play a pivotal role in advancing GSK's HIV pipeline, with direct impact on patient safety and global health outcomes., We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.
This role is hybrid, based at our London United Kingdom HQ with expectations to be on site a minimum of 2 days per week.
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people's lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients' needs and have the highest probability of success. We're uniting science, technology, and talent to get ahead of disease together.
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases - to impact health at scale.
People and patients around the world count on the medicines and vaccines we make, so we're committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.